Review



mouse recombinant tsp1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems mouse recombinant tsp1
    Mouse Recombinant Tsp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse recombinant tsp1/product/R&D Systems
    Average 94 stars, based on 17 article reviews
    mouse recombinant tsp1 - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems mouse recombinant tsp1
    Mouse Recombinant Tsp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse recombinant tsp1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mouse recombinant tsp1 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    90
    R&D Systems recombinant mouse tsp1
    ( A ) Representative images of <t>TSP1</t> staining (black arrow) of tumor removed from WT and CD47 −/− mice (Scale bar, 20 μm). ( B ) TSP1 mRNA levels in tumor samples from WT and CD47 −/− mice quantified by real-time PCR assay ( n = 4/group). ( C ) Representative images of tumor sections stained for F4/80 (red; Scale bar, 20 μm). ( D ) Percentages of F4/80 + cells ( n = 3/group). Data are mean ± SDs. ** P < 0.01; *** P < 0.001.
    Recombinant Mouse Tsp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse tsp1/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    recombinant mouse tsp1 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Representative images of TSP1 staining (black arrow) of tumor removed from WT and CD47 −/− mice (Scale bar, 20 μm). ( B ) TSP1 mRNA levels in tumor samples from WT and CD47 −/− mice quantified by real-time PCR assay ( n = 4/group). ( C ) Representative images of tumor sections stained for F4/80 (red; Scale bar, 20 μm). ( D ) Percentages of F4/80 + cells ( n = 3/group). Data are mean ± SDs. ** P < 0.01; *** P < 0.001.

    Journal: Oncotarget

    Article Title: CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis

    doi: 10.18632/oncotarget.9899

    Figure Lengend Snippet: ( A ) Representative images of TSP1 staining (black arrow) of tumor removed from WT and CD47 −/− mice (Scale bar, 20 μm). ( B ) TSP1 mRNA levels in tumor samples from WT and CD47 −/− mice quantified by real-time PCR assay ( n = 4/group). ( C ) Representative images of tumor sections stained for F4/80 (red; Scale bar, 20 μm). ( D ) Percentages of F4/80 + cells ( n = 3/group). Data are mean ± SDs. ** P < 0.01; *** P < 0.001.

    Article Snippet: Where indicated, recombinant mouse TSP1 (R&D Systems) was added into the outer chamber.

    Techniques: Staining, Real-time Polymerase Chain Reaction

    ( A – B ) Dose-dependent recruitment of F4/80 + macrophages by TSP1 measured by Transwell assay. Shown are representative images of DAPI-stained macrophages (Scar bar, 50 μm) in the outer chamber (A) and numbers of macrophages per 100× microscopic filed (B). ( C ) TSP1 mRNA levels in 24-hr cultured tumor cells from WT and CD47 −/− mice ( n = 4/group). ( D – E ) Recruitment of WT macrophages by cultured tumor cells from WT mice, CD47-deficient mice without (CD47 −/− ) or with (CD47 −/− + TSP1) recombinant mTSP1 (2.2 nM). Shown are representative flow cytometry profiles (D) and percentages (E) of F4/80 + macrophages in the outer chambers. ( F – G ) Recruitment of WT (WT MΦ) and CD47-deficient (CD47 −/− MΦ) macrophages by cultured tumor cells from WT or CD47-deficient mice. Shown are representative flow cytometry profiles (F) and percentages (G) of F4/80 + macrophages in the outer chamber of the transwell plate. Data are mean ± SDs. * P < 0.05, ** P < 0.01; *** P < 0.001.

    Journal: Oncotarget

    Article Title: CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis

    doi: 10.18632/oncotarget.9899

    Figure Lengend Snippet: ( A – B ) Dose-dependent recruitment of F4/80 + macrophages by TSP1 measured by Transwell assay. Shown are representative images of DAPI-stained macrophages (Scar bar, 50 μm) in the outer chamber (A) and numbers of macrophages per 100× microscopic filed (B). ( C ) TSP1 mRNA levels in 24-hr cultured tumor cells from WT and CD47 −/− mice ( n = 4/group). ( D – E ) Recruitment of WT macrophages by cultured tumor cells from WT mice, CD47-deficient mice without (CD47 −/− ) or with (CD47 −/− + TSP1) recombinant mTSP1 (2.2 nM). Shown are representative flow cytometry profiles (D) and percentages (E) of F4/80 + macrophages in the outer chambers. ( F – G ) Recruitment of WT (WT MΦ) and CD47-deficient (CD47 −/− MΦ) macrophages by cultured tumor cells from WT or CD47-deficient mice. Shown are representative flow cytometry profiles (F) and percentages (G) of F4/80 + macrophages in the outer chamber of the transwell plate. Data are mean ± SDs. * P < 0.05, ** P < 0.01; *** P < 0.001.

    Article Snippet: Where indicated, recombinant mouse TSP1 (R&D Systems) was added into the outer chamber.

    Techniques: Transwell Assay, Staining, Cell Culture, Recombinant, Flow Cytometry